NCT01588704View on ClinicalTrials.gov

Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions
Lung Cancer
Interventions
DRUG

Neoadjuvant Bevacizumab

Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab followed by surgical resection

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Si-Yu Wang

OTHER

NCT01588704 - Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma | Biotech Hunter | Biotech Hunter